USNA NYSE Week ended 31 Jul 2026

Weekly Investor Report

USANA Health Sciences Inc · Consumer Defensive · Packaged Foods

Open interactive chart View report data
Latest close 22.11 USD
3.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 11.6% above the Trend Line and sits at 35.1% of its 52-week range. The latest completed week returned 3.7%, after a 2.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is volatility with 48/100 conviction, while the latest news-sentiment score is 60/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 36 out of 100
Latest Close 22.11 USD 31 Jul 2026
1W Return 3.7% latest completed week
4W Return 2.8% short-term follow-through
12W Return 16.6% quarterly tape
Trend Breadth 13.5% 7 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 1-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 43.86% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.7% Latest completed week; four-week move 2.8%. Indicator stack 11/65 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.86% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 48/100 conviction; expected move 18.4%. News sentiment 60/100 37 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.6% above the Trend Line and sits at 35.1% of its 52-week range. The latest completed week returned 3.7%, after a 2.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3912-week average 0.16

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.39Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.8% over four weeks, 16.6% over 12 weeks, and -23.4% over one year. The current trend has remained active for 1 consecutive weeks.

Performance by holding period

1W3.7%
4W2.8%
12W16.6%
26W1.9%
52W-23.4%
Active trend streak1 weeks
Active weeks in one year7
Trend breadth13.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.94Latest activity-pressure read.
Pressure change-18.8%Four-week change in activity pressure.
Leadership-6.74Latest relative-leadership reading.
RS change49.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength60/100Blend of value, momentum, and quality. Underlying universe rank 41; rank 1 is best.
Value89/100Relative valuation strength. Underlying universe rank 12; rank 1 is best.
Quality27/100Profitability and accounting quality. Underlying universe rank 74; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth2/100Revenue and earnings growth. Underlying universe rank 99; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework92/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
44.4x
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
3.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
10.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
76.7%
Gross profit retained from each unit of revenue.
Operating margin
4.4%
Operating profit retained from revenue.
Free-cash-flow margin
3.3%
Free cash flow generated from revenue.
Return on invested capital
2.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
5.7%
Latest one-year revenue growth.
EPS growth
-74.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-55.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
3.9%
Net share repurchases relative to market value.
Shareholder yield
3.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

USNA shows volatility options pressure with a 48/100 conviction score, put-call volume ratio of 2.00, expected move of 18.4%, and Sharemaestro trend signal inactive.

Conviction48/100
Expected move18.4%
Put/call volume2.00
Pressure-33
Speculation4
Volatility93
Trend agreement94
Open options detail
Insider activity11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment60/100

Weighted news tone is neutral across 37 relevant articles.

16 positive · 18 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move18.4%Nearest-chain priced movement where available.
52-week drawdown-31.6%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+10.8%Week of 17 Apr.
Worst week-17.1%Week of 6 Mar.
Latest week+3.7%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains5
Flat weeks0
Modest losses13
Sharp losses3
Recent vol4.9%13-week weekly-return volatility.
Base vol6.0%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew4.3% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape30/100

Trend, activity pressure, participation, and risk combine to a 30/100 tape read.

 Indicator analysis37/100

Latest 12-week confirmation: trend 1/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.39; No reversal markers Next-Week ExpectancyNegative 43.86%

Next-week expectancy is negative with a 43.86% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors46/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 15; Small Cap Core rank 25 SVQF92/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 80.5 of 1013 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options61/100

USNA shows volatility options pressure with a 48/100 conviction score, put-call volume ratio of 2.00, expected move of 18.4%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 18.4% Sentiment60/100

Weighted news tone is neutral across 37 relevant articles.

Glow-Promoting Cellular Nutrition Formulas Insiders11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202622.11 USD3.7%19.82 USD35.04 USD0.94-6.74466.3KOn
24 Jul 202621.32 USD-2.3%19.73 USD35.32 USD0.96-10.03460.5KOff
17 Jul 202621.82 USD-0.7%19.68 USD35.60 USD1.09-9.64403.3KOff
10 Jul 202621.98 USD2.2%19.62 USD35.87 USD1.15-11.41462.2KOff
3 Jul 202621.51 USD3.9%19.56 USD36.12 USD1.16-13.36420.5KOff
26 Jun 202620.70 USD9.6%19.51 USD36.38 USD0.94-15.98650.3KOff
19 Jun 202618.88 USD-5.2%19.48 USD36.65 USD0.56-26.15619.9KOff
12 Jun 202619.91 USD10.4%19.51 USD36.92 USD0.31-22.56520.2KOff
5 Jun 202618.03 USD-1.5%19.48 USD37.18 USD0.09-30.37548.1KOff
29 May 202618.30 USD-2.3%19.52 USD37.47 USD0.07-32.03444.8KOff
22 May 202618.74 USD4.2%19.61 USD37.76 USD0.04-30.40575.5KOff
15 May 202617.98 USD-5.2%19.68 USD38.04 USD-0.03-33.57780.1KOff
8 May 202618.96 USD-2.0%19.78 USD38.34 USD-0.09-30.79580.5KOff
1 May 202619.35 USD-0.5%19.82 USD38.64 USD-0.16-28.70385.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.